Alina John
Contents contributed and discussions participated by Alina John
Collagen Peptide and Gelatin Market: APAC to Emerge as Most Lucrative Region Owing to R... - 1 views
-
Surging awareness about physiological well-being and personal healthcare drives the growth of the global collagen peptide and gelatin market, states a recently published report by Transparency Market Research. The report is titled "Collagen Peptide and Gelatin Market - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2014 - 2020" and is available for sale on the company website.According to the report, the global collagen peptide market is poised to grow from US$0.7 billion in 2013 to US$1.1 billion in 2020, registering a 6.8% CAGR during the forecast period. The gelatin market, on the other hand, was worth US$1.8 billion in 2013 and is estimated to be worth US$3.0 billion by 2020, developing at a 7.5% CAGR from 2014 to 2020.
Browse the full Collagen Peptide and Gelatin Market Report at http://www.transparencymarketresearch.com/collagen-peptide.html
The collagen peptide and gelatin market is segmented on the basis of type of sources, applications, and geography. Geographically, the global collagen peptide and gelatin market is divided into North America, Europe, Asia Pacific, and Rest of the World. Owing to the increased popularity of cosmeceuticals, rise in R&D activities, and growing awareness about nutraceuticals, North America dominated the collagen peptide market in 2013. The gelatin market, however, was led by Europe owing to flourishing pharmaceutical and food and beverages industries and presence of several research organizations in the field of nutritional products. The Asia Pacific market for collagen peptide and gelatin is set to be the most promising regional segment from 2014 to 2020 owing to rising importance of nutrition and personal well-being and steady pace of industrialization.
The key sources of gelatin are chicken, porcine, marine, bovine, and others such as donkey, horse, cat, and dog. The major applications areas of gelatin are pet food, cosmeceuticals, food and beverages, ballistics, bone and joint health, pharmaceuticals, nutraceuticals, photography, and India ink. Porcine gelatin led the global market, with marine gelatin likely to register the highest CAGR over the forecast period. By application, the use of gelatin in the food and beverages segment held the largest share of the market, with bone and health being the fastest growing application segment from 2014 to 2020.Marine collagen peptide was the largest as well as the most rapidly developing segment in 2013 and is estimated to retain its lead during the course of the forecast period. Cosmeceuticals was the dominant segment of the collagen peptide market in terms of application and it held a 20% share in the global market. However, the use of collagen peptide in applications such as wound healing and regenerative medicine will be the fastest growing segment by 2020.
Browse the full Press Release Report :
http://www.transparencymarketresearch.com/pressrelease/collagen-peptide.htm
The collagen peptide and gelatin market is rather consolidated, with a select few players dominating the global market. The major players featured in the collagen peptide and gelatin market report are ChinaTech Peptide Co. Ltd., Nitta Gelatin, Inc., Sterling Gelatin, BioCell Technology LLC, InterHealth Nutraceuticals, Inc., Capsugel Belgium NV, Roxlor LLC, Weishardt International Group, GELITA AG, Norland Products, Inc., Pont Brule (PB) Gelatins GmbH, Amicogen, Inc., Catalent, Inc., and Rousselot International. Among these, GELITA AG dominated by gelatin market in 2013, while Rousselot International led the collagen peptide market the same year.
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1070
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
G-Protein Coupled Receptors (GPCRs) Market : Global Industry Analysis, Size, Share, Gro... - 1 views
-
This report on G-protein coupled receptors (GPCRs) market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies engaged in manufacturing and commercialization of GPCR assays, cell lines, and consumables and entrants that are planning to invest in the GPCRs market. This report comprises an elaborate executive summary, which includes a market snapshot providing overall information of various segments and sub-segments included in the study scope. This section also provides overall information and data analysis of the global GPCRs market with respect to the leading market segments based on types of products, applications and geographic regions.
Browse Full G-Protein Coupled Receptors (GPCRs) Market Report With Complete TOC @
http://www.transparencymarketresearch.com/g-protein-coupled-receptors-market.html
The global GPCRs market has been segmented based on of assay type, therapeutic area, and geography. Based on assay type, the GPCRs market has been categorized into six major segments: cAMP assays, calcium level detection assays, GTPγS binding assays, reporter gene assays, receptor internalization assays, and cGMP assays. The market for these segments has been extensively analyzed based on of their effectiveness, usefulness, sales, and geographic presence. Market revenue in terms of USD million for the period between 2012 and 2022 along with the compound annual growth rate (CAGR %) from 2014 to 2022 are provided for all the segments, considering 2013 as the base year.
In terms of therapeutic areas, the market has been segmented into seven categories: cardiovascular system, central nervous system (CNS), respiratory system, immune system, reproductive system, oncology, and others (abdominal, urinary, orthopedics, etc.). Market revenue in terms of USD million for the period between 2012 and 2022 along with the compound annual growth rate (CAGR %) from 2014 to 2022 are provided for all the segments, considering 2013 as the base year.
The market overview section of the report explores market dynamics such as drivers, restraints, and opportunities that have strong impact on the GPCRs market currently and could influence the market in future as well. The market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. Porter's Five Forces analysis is also explained in this section to understand the GPCRs market considering different parameters that have an impact on the sustainability of the companies operating in the GPCRs market. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.
Browse Full Press Release Report : http://www.transparencymarketresearch.com/pressrelease/g-protein-coupled-receptors-market.htm
Geographically, the GPCRs market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). Major geographic regions have been further divided into major national markets, viz. North America (the U.S. and Canada), Europe (Germany, the U.K., France, and Rest of Europe), and Asia Pacific (China, Japan, India, and Rest of Asia Pacific). Moreover, Rest of the World has been further subdivided into three regions: Latin America, the Middle East, and Africa. Market revenue in terms of USD million for the period between 2012 and 2022 along with the CAGR % from 2014 to 2022 are provided for all the regional and national markets considering 2013 as the base year.
The recommendations section included in the report would assist existing market players in expanding their market shares and new companies in establishing their presence in the global market. The report also profiles major players in the GPCRs market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Thermo Fisher Scientific, Inc., EMD (Merck) Millipore, Becton, Dickinson and Company, PerkinElmer, Inc., Cisbio Bioassays, Enzo Life Sciences, Inc., DiscoveRx Corporation, Sigma-Aldrich Corporation, QIAGEN N.V., Promega Corporation, Abcam plc, and HD Biosciences Co. Ltd.
The global GPCRs market is segmented as follows:
GPCRs Market, by Assay Type
Calcium Level Detection Assays
GTPγS Binding Assays
cGMP Assays
Reporter Gene Assays
Receptor Internalization Assay
cAMP Assays
GPCRs Market, by Therapeutic Area
Cardiovascular System
Central Nervous System
Respiratory System
Immune System
Reproductive System
Oncology
Others
GPCRs Market, by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
France
Rest of Europe
Asia Pacific
China
Japan
India
Rest of Asia Pacific
Rest of the World (RoW)
Latin America
Middle East
Africa.
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=b&rep_id=550
About Us
Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Acidity Regulators Market in terms of revenue is expected to Reach USD 6.34 Billion in ... - 1 views
-
According to a new market report published by Transparency Market Research "Acidity Regulators Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2021," the acidity regulators market was valued at USD 3.93 billion in 2014, which is expected to reach USD 6.34 billion by 2021, growing at a CAGR of 7.3% from 2015 to 2021.
Browse the full Acidity Regulators Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2021 report at http://www.transparencymarketresearch.com/acidity-regulators-market.html
Acidity regulators are also known as pH control agents, which form an integral part in the food additives market. Acidity regulators are used to increase the shelf life of the food. In addition, acidity regulators prevent any microscopic organism from damaging the food and increase the food preservation.
Increasing demand for acidity regulators from the food and beverage industry is fuelling the acidity regulators market globally. The demand for processed foods and ready to drink beverages has gradually increased over the years among the consumers globally. Owing to the demand for these products, the demand for acidity regulators has increased simultaneously and is expected to have a stable growth during the forecast period.
acidity-regulators-market
The consumption of acidity regulators have several adverse effect on the human body which is the restraining the market. Consumption of acidity regulators has adverse effects such as vomiting, nausea, diarrhea and several other complications. Moreover, over consumption of such acids result in tooth decay.
Asia Pacific held the largest market share for acidity regulators followed by North America. Asia Pacific is also the fastest growing market for acidity regulators followed by Rest of the World (RoW). Citric acid held the largest market share in acidity regulators globally. Cargill Incorporated, Tate and Lyle pcl, Jungbunzlauer A.G., Corbion N.V., Archer Daniels Midland Co. among others are some of the key players operating in the global acidity regulators market
The report studies the Global Acidity Regulators Market and provides estimates in terms of revenue (USD Billion) from 2015 to 2021. Market estimates on the basis of product type have also been provided for each country.
Browse the full Press Release Report: http://www.transparencymarketresearch.com/pressrelease/acidity-regulators-market.htm
The market has been segmented as follows:
Global Acidity Regulators Market, by Product Type
Citric Acid
Phosphoric Acid
Acetic Acid
Malic Acid
Lactic Acid
Global Acidity Regulators Market, by Application
Beverages
Processed Foods
Sauces and Condiments
Bakery
Confectionery
Global Acidity Regulators Market, by Geography
North America
Europe
Asia Pacific
Rest of the World
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=4690
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Hot Dogs and Sausages Market is expected to reach USD 80.45 billion by 2021 - 1 views
-
Transparency Market Research has published a new market report titled "Hot Dogs and Sausages Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2021." According to the report, the global hot dogs and sausages market was valued at USD 64.76 billion in 2014 and is estimated to reach USD 80.45 billion in 2021, growing at a CAGR of 3.1% from 2015 to 2021. In terms of volume the global hot dogs and sausages market was valued at 5,664.7 Kg-million in 2014 and is expected to reach 6,443.6 Kg-million by 2021, growing at a CAGR of 1.8% over the forecast period. Among different regions, the Middle East and Africa (MEA) market is expected to grow at the highest CAGR both in terms of revenue and volume over the forecast period. The Middle East and Africa hot dogs and sausages market in terms of revenue and volume is projected to grow at a CAGR of 3.4% and 2.9% respectively from 2015 to 2021. In terms of revenue and volume, Asia Pacific held the largest market for hot dogs and sausages in 2014 and is expected to retain its position as the market leader over the forecast period.
Browse the full Hot Dogs and Sausages Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2021. report at http://www.transparencymarketresearch.com/hot-dogs-sausages-market.html
hot-dogs-sausages-market
The major factors driving the growth of the hot dogs and sausages market are increasing number of households having kids, popularity of hot dogs and sausages among younger generation and busy lifestyle of working class globally.
Among the different product categories of hot dogs and sausages, cocktail sausages held the largest market share in both value and volume terms in 2014 and is expected to remain the market leader by 2021.
Major players like Bar-S Foods Company, ConAgra Foods Inc, Bob Evans Farms Inc, and Johnsonville Sausage LLC among others are expected to capture the attention of consumers due to their cost effectiveness vis-à-vis branded products.
Browse the full Press Release Report :
http://www.transparencymarketresearch.com/pressrelease/hot-dogs-sausages-market.htm
The Hot Dogs and Sausages Market has been segmented as follows:
Global Hot Dogs and Sausages Market by Meat Type
Meat types covered under this research study are:
Pork
Beef
Chicken
Others
Global Hot Dogs and Sausages by Product Type
Product types covered under this research study are
Frozen Hot Dogs and Sausages
Refrigerated Breakfast Sausages
Refrigerated Dinner Sausages
Refrigerated Hot Dogs
Cocktail Sausages
Others
Global Hot Dogs and Sausages Market by Geography
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=4650
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact
Mr.Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Asia Pacific Region to Dominate the Global FMD Vaccines Market - 1 views
-
Transparency Market Research has released a new report on the global foot and mouth disease (FMD) vaccines market, which forecasts the growth of the overall FMD vaccines market at a CAGR of 8.8% during the period from 2014 to 2020. The FMD vaccines market was valued at US$0.51 billion in 2013. Due to the increasing frequency of FMD outbreaks, the report projects that the market will reach a worth of US$0.95 billion by the end of 2020. The report is titled 'Foot and Mouth Disease Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020'.
Browse the full Foot and Mouth Disease Vaccines Market Report at http://www.transparencymarketresearch.com/foot-mouth-disease-vaccines.html
Caused by Aphthovirus, FMD is highly infectious viral disease which affects cloven-hoofed animals and leads to high mortality rate among the young stock such as lambs and piglets. The high prevalence of FMD across the globe affects the international trade in livestock products. The report provides an overview of the overall global FMD vaccines market and evaluates the growth drivers and restraints. Favorable government initiatives to control FMD outbreaks have boosted the growth of the global FMD vaccines market. Also, rising consumption of meat and dairy products demands healthy livestock, which has further fuelled the need for FMD vaccines. The report mentions that the involvement by various governments in purchasing FMD vaccines will lead to the dip in cost which will negatively affect the global FMD vaccines market in terms of revenue. FMD is caused by seven different types of serotype and the current vaccines are serotype-specific. Unpredictable serotype outbreaks can hamper the growth of the global FMD vaccines market. The report indicates that DNA vaccines will open new opportunities for the market during the forecast period.
Depending upon the type of vaccines, the report segments the global FMD vaccines market into conventional vaccines and emergency vaccines. The conventional vaccines have been further categorized into aluminum hydroxide or Saponin based vaccines, and oil-based vaccines. In 2013, oil-based FMD vaccines dominated the global FMD vaccines market with a market share of 63%, owing to its high efficiency and longer effect in treating the disease.
On the basis of application on the livestock, the global FMD vaccines market has been divided into cattle, pigs, sheep and goats, and others. To meet the increasing demand for milk and meat, cattle are reared the most across the globe, owing to which it has emerged as the largest application segment of the global FMD vaccines market. In Middle-east, as pork consumption is prohibited, the cattle segments contribute significantly to the FMD vaccines market of the region. The report predicts that the cattle segment will exhibit the fastest growth during the forecast horizon.
Browse the full Press Release Report:
http://www.transparencymarketresearch.com/pressrelease/foot-mouth-disease-vaccines.htm
Geographically, the global FMD vaccines market has been segmented into four key regions: Europe, North America, Asia Pacific, and Rest of the World. As the disease is non-existent in North America and Europe, the scope of the growth of the vaccines market in these regions is negligible. Due to frequent outbreaks of FMD in Asia Pacific region, the global FMD vaccines market has been dominated by this region with more than 70% share. The report documents the market revenue in China, India, Malaysia, South Korea, and rest of APAC during the forecast period. The report profiles some of the key vendors of the global FMD vaccines market such as Indian Immunologicals Ltd., Bayer AG, Agrovet Co., and Brilliant Bio Pharma Ltd.
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=2480
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Hospital Infection Therapeutics Market to be Propelled by Rising Incidence of Hospital ... - 1 views
-
A recent study by Transparency Market Research (TMR) forecasts that the global hospital infection therapeutics market will grow at a CAGR of 3.1% between 2014 and 2020. TMR, a market intelligence company based in the United States, in its recently released report states, that the global hospital infection therapeutics market is anticipated to reach a market value worth US$3.62 billion by 2020 from US$3.06 billion in 2013. The report titled "Hospital Infection Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" is available for sale on the website.
Browse the full Hospital Infection Therapeutics Market Report at http://www.transparencymarketresearch.com/hospital-infection-therapeutics.html
According to this market research report, a growing geriatric population, rising demand for better therapeutic drugs, high incidence of hospital infections, and greater healthcare awareness are a few of the prominent factors that drive the global hospital infection therapeutics market. The infections which the patients undergoing treatments in hospitals contract during their stay in the hospitals are known as hospital-acquired infections (HAI) or hospital infections. These infections spread in healthcare settings such as nursing homes, rehabilitation centers, hospitals, dialysis centers, and outpatient surgery centers. It has been observed that most cases of hospital infections originate from the ICUs (Intensive Care Units) as against other divisions.
The TMR report segments the global hospital infection therapeutics market on the basis of drug type, major infections, and geography. On the basis of drug type, this market is segmented into antifungal drugs, antibacterial drugs, and antiviral drugs. Based on major infections, the hospital infection therapeutics market is segmented into bloodstream infections, gastrointestinal disorders, hospital-acquired pneumonia (HAP), urinary tract infections, surgical site infections, and other hospital infections.In 2013, the largest share in the global hospital infection therapeutics market was held by the segment for hospital-acquired pneumonia, with a market share more than 20%. However, the segment for urinary tract infections will grow at a rapid rate in the forthcoming years.
Geographically, this research study classifies the global hospital infection therapeutics market into Asia Pacific, Europe, North America, and Rest of the World. In revenue terms, North America dominates the overall hospital infection therapeutics market. The second largest market after North America is Europe. High demand for advanced drugs, high incidence of hospital infections, increasing number of multidrug-resistant microbial pathogens are the key factors that propel the North America hospital infection therapeutics market. The other factors driving the North America market are high income levels and greater healthcare awareness amongst the masses. However, owing to increasing income levels, rising awareness, and better healthcare infrastructure, it is the Asia Pacific hospital infection therapeutics market that will witness highest growth rate in the years to come.
Browse the full Press Release Report :
http://www.transparencymarketresearch.com/pressrelease/hospital-infection-therapeutics.htm
Key factors that hamper the growth of the overall hospital infection therapeutics market are greater number of multi-drug resistant bacterial strains and greater infection control and hospital surveillance programs in advanced economies leading to lower incidence of hospital infections.
Some of the key companies in the global hospital infection therapeutics market include Sanofi, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline plc, Bristol-Myers Squibb Company, AstraZeneca plc, and Actavis plc.
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1280
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Global API Market to be hampered by Stern Regulatory Policies in European Union - 1 views
-
The recent patent expiry of several blockbuster drugs has presented specialized active pharmaceutical ingredients (API) manufacturers with ample opportunities for expansion all over the world. The bioactive portions of any drug are made up of APIs. The U.S. FDA defines APIs as a material or an amalgam of materials utilized in the manufacture of a drug and one that becomes an active ingredient of the drug upon production. APIs present patients with health benefits and assist in diagnosing, preventing, and curing diseases, though the result of and reactions to the drug vary from patient to patient depending on the dosage consumed.
Browse Full Global API Market Report With Complete TOC @ http://www.transparencymarketresearch.com/active-pharmaceutical-ingredients.html
In the recent past, the increase in abbreviated new drug applications has stimulated the demand for APIs. Additionally, several Indian pharmaceutical companies are joining the rapidly growing global API market. However, the stern regulatory policies in the European Union are restricting the rise of this market.
In 2013, the global API market had reached a value of US$119.7 billion. By 2020, the market is estimated to be worth US$185.9 billion, developing at a CAGR of 6.5% during the period from 2014 to 2020.
In-house API manufacturing Market in Declining Phase Due to High Level of Competition
The captive or in-house API manufacturing market and the API contract manufacturing market are the segments of the global API market based on the type of manufacturing. Hitherto, the captive API manufacturing market was the dominant segment, but, at present, the market is losing ground owing to the high level of competition coupled with decreased profitability. Correspondingly, the API contract manufacturing market is registering impressive growth.
Based on the types of API, this market is classified into the synthetic chemical API market and the biological API market, in which the biological API market is undergoing major expansion on account of the attention giant pharma companies have started to pay to this market segment.
Browse Full Press Release Report:
http://www.transparencymarketresearch.com/pressrelease/active-pharmaceutical-ingredients.htm
The API market is dominated by generic prescriptions drugs based on the types of drugs and, owing to the global volume rise in generic prescription drugs, the demand for APIs is expected to witness a swift increase across the globe.
Apart from this, the oncology drugs market is likely to report the fastest growth in the global API market in terms of therapeutic area. The growth of this market is expected to boost demand for APIs to a large extent.
API market in North America to Maintain its Dominance
The global market for API is spread across North America, Europe, Asia Pacific, and Rest of the World, wherein the market is led by North America on the account of the increasing demand for APIs in drug formulations and the rise in R&D programs. Analysts expect the region to maintain its dominance in the near future. In response to high medical and healthcare costs in the U.S., the preference for generic medicines is on the rise, fueling growth of the API market in this region. The API market in Asia Pacific stands at the second position in the geographical hierarchy of the global market, due to the presence of generic medicine producers in large numbers.
The major players in the global API market are Actavis plc, Boehringer Ingelheim Group, BASF SE, Cambrex Corporation, Hospira, Inc., Dr. Reddy's Laboratories Ltd., Lonza Group, Novartis International AG, Mylan, Inc., Pfizer, Inc., WuXi Apptec, and Teva Pharmaceutical Industries Ltd. However, the market consists of more than 2,500 participants, making it highly fragmented in nature. The recent approval of ZarxioTM (first biosimilar in the U.S.) of Sandoz - the generic pharma division of Novartis - is expected to add significantly to overall revenue generated in the global API market.
Request a Brochure of this Report
http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1690
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Global Peptide Therapeutics Market to be Fueled by Increasing Prevalence of Cancer and ... - 1 views
-
The global market for peptide therapeutics market derives much of its demand from the treatment of cancer and diabetes. The rising incidence of these diseases is making way for the advancement of peptide drugs, which in turn is propelling the global peptide therapeutics market. Additionally, the technical advancements in peptide drugs have resulted in a reduction in total production cost, fueling the production process of new peptide drugs.
Browse Full Global Peptide Therapeutics Market Report With Complete TOC @ http://www.transparencymarketresearch.com/peptide-therapeutics-market.html
On the other hand, API manufacturers are facing a tough challenge from the complex structure of peptides. Other than this, the lack of regulatory standards to arbitrate developments in peptide drugs is also hampering the growth of the peptide therapeutics market. However, biotech enterprises are identifying prospects for future growth in collaboration with major pharmaceutical firms across the globe.The global peptide therapeutics market is expected to expand at a CAGR of 2.8% during the period from 2014 to 2020 in order to reach US$23.7 billion by 2020. The market had reached a value of US$18.9 billion in 2013.
Market for Respiratory Disorders Poised to Grow at Highest CAGR between 2014 and 2020
Peptide therapeutics find application in the treatment of various kinds of ailments such as cardiovascular, nervous, gastrointestinal, respiratory, metabolism-related, in addition to cancer, various infections, and pain. The cancer market was the dominant application segment of the peptide therapeutics market in 2013. However, the respiratory disorder market segment is projected to develop at the highest CAGR during the period from 2014 to 2020 owing to the recent approval of lucinactant, sold under the brand name Surfaxin.
The global peptide therapeutics market is analyzed on three fronts: Route of administration, marketing status, and regional distribution of the global industry. Based on route of administration, parenteral and oral are the two segments of this market, while branded peptide therapeutics and generic peptide therapeutics are the segments of the global market on the basis of marketing status. The market for generic peptides is expected to do well in the next few years on account of patent expirations expected in the branded peptide market in the near future.
Asia Pacific to Report Highest Compound Annual Growth Rate from 2014 to 2020
Regionally, the global peptide therapeutics market is distributed among North America, Europe, Asia Pacific, and the Rest of the World, wherein the global market is dominated by the North American and European markets, which jointly occupy over 60% of the global market. However, in spite of the dominance of these regions in the global market, the peptide therapeutics market in Asia Pacific is poised to grow at the highest CAGR during the period from 2014 to 2020.The peptide therapeutics market in Asia Pacific is majorly driven by the rapid growth of this market in China, India, and Japan. The rise in economic stability and increased awareness pertaining to the treatment of various diseases are the major factors fueling the growth of the market in this region.
Browse Full Press Release Report: http://www.transparencymarketresearch.com/pressrelease/peptide-therapeutics-market.htm
Japan is the second largest market in the global individual pharmaceutical industry, whereas China and India have a huge population pool suffering from various diseases and ailments that are cured with the help of peptide therapeutics. These factors are expected to establish Asia Pacific as the most promising market for peptide therapeutics in the near future. China and India are also emerging as some of the largest peptide API suppliers in the world.
Amgen, Inc., Bachem Holding AG, AstraZeneca Plc, CordenPharma Int. GmbH, Ipsen S.A., Eli Lilly and Co., Lonza Group Ltd., Novartis AG, Merck & Co., Inc., Novo Nordisk A/S, Roche Holdings AG, PolyPeptide Group, Sanofi, Millennium Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., and Takeda Pharmaceutical Co. Ltd. are the major enterprises working in the global peptide therapeutics industry. The market is mostly concentrated as Takeda, Teva, and Novo Nordisk collectively hold more than 50% of the overall peptide therapeutics market.
The forthcoming patent expiry of Copaxone by Teva and Velcade by Millennium Pharma and the projected launch of their generic alternatives are expected to change the dynamics of the global peptide therapeutics market in the near future.
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=418
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Contact
Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Chemotherapy Induced Nausea and Vomiting (CINV) Existing and Pipeline Drugs Market Expe... - 1 views
-
According to a new market report published by Transparency Market Research "CINV Existing and Pipeline Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020," the global CINV drugs market was valued at USD 1.28 billion in 2013 and is expected to grow at a CAGR of 5.7% from 2014 to 2020, to reach an estimated value of USD 1.88 billion in 2020.
Browse the full CINV Existing and Pipeline Drugs Market Report at http://www.transparencymarketresearch.com/cinv-market.html
Chemotherapy induced nausea and vomiting (CINV) refers to nausea and vomiting associated with cancer chemotherapy. CINV is one of the most common side effects experienced by cancer patients undergoing chemotherapy. Although there are currently several drugs available to manage CINV, this side effect continues to be a major concern for patients and oncologists associated with chemotherapy. Companies such as Helsinn Holding S.A., Heron Therapeutics, Inc. and Tesaro, Inc. are striving to develop new and more efficacious therapeutic solutions to treat CINV.
cinv-market
Aloxi (palonosetron), Zofran (ondansetron), Kytril (granisetron) and Emend (aprepitant) are the major available drugs which are used to manage CINV. Recently in October 2014, U.S. FDA approved the first fixed combination oral agent, Akynzeo (developed by Helsinn Holding S.A.) for the prevention of CINV. Akynzeo, being the first fixed-dose combination providing patients with two antiemetics in a single dose, is likely to offer better patient compliance and consequently is expected to witness increasing popularity among physicians.
SUSTOL (APF-530) and rolapitant are the two major CINV pipeline drugs that are currently under phase III or registration phase and would be introduced in the near future. Approval of these two pipeline drugs will be driving the overall CINV drugs market during the forecast period from 2014 to 2020. In addition to this, continuous increase in number of patients undergoing chemotherapy is also expected to play a key role in the growth of CINV drugs market. Various sources indicate that approximately 70% to 80% cancer patients on chemotherapy exhibit nausea and vomiting as major side effects.
Two key CINV drugs Aloxi and Emend are going off-patent in 2015, post which a number of generic manufacturers are likely to enter in the market with generic versions of these two brands. Therefore, patent expiry of Aloxi and Emend has been anticipated to affect market revenue during the forecast period, as their generic versions will be sold at 80% to 85% lower prices than the branded ones.
Browse the full Press Release Report :
http://www.transparencymarketresearch.com/pressrelease/cinv-market.htm
Geographically, North America was the largest regional market for CINV drugs in 2013 with a market share of over 45% of the total revenue generated globally, followed by Europe. North America it is expected to retain its leading position through 2020, growing at a CAGR of more than 7% during the forecast period from 2014 to 2020. On the other hand, the CINV drugs market in Asia-Pacific would be primarily driven by the increasing penetration of western companies coupled with the growing number of cancer patients. In many countries in Asia-Pacific and Rest of the World (RoW) regions, generic manufacturers would be competing with the branded CINV drug manufacturers. Owing to the low purchasing power of people, generic versions of expired branded drugs are in greater demand in the region.
GlaxoSmithKline plc, Helsinn Holding S.A., Heron Therapeutics, Inc., Merck & Co., Inc. and Tesaro, Inc. are some of the key players actively participating in the CINV drugs market.
The global CINV existing and pipeline drugs market is segmented as follows:
CINV Existing and Pipeline Drugs Market Revenue (USD Million), by Major Drugs
Aloxi (palonosetron)
Zofran Generic (ondansetron)
Kytril Generic (granisetron)
Emend (aprepitant)
Akynzeo (netupitant-palonosetron)
SUSTOL (extended release granisetron injection)
Rolapitant
CINV Existing and Pipeline Drugs Market Revenue (USD Million), by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=776
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Mr.Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Mouth Ulcers Treatment Market to Exhibit 3.8% CAGR from 2014 to 2020 Due to Increasing ... - 1 views
-
A new market research report has been recently published by Transparency Market Research (TMR), a U.S.-based market research and intelligence firm. The report provides a comprehensive analysis of the global mouth ulcers treatment market, along with elaborative description of the segmentation, historical data, and growth prospects of the market. The research report is titled "Mouth Ulcers Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020".
Browse the full Mouth Ulcers Treatment MarketReport at http://www.transparencymarketresearch.com/mouth-ulcers-treatment.html
According to the research study, in 2013, the global mouth ulcers treatment market stood at US$1.2 billion and is anticipated to approach US$1.6 billion by the end of 2020, growing significantly at 3.8% CAGR between 2014 and 2020.Rising awareness among people regarding mouth ulcers and growing geriatric population are the two major factors expected to boost demand for mouth ulcers treatment in the forecast period. Asia Pacific holds considerable growth prospects for the market players. However, side-effects of mouth ulcers treatment such as constipation, blurred vision, headache, and stomach pain pose a threat to rising demand for mouth ulcers treatment products across the globe.
On the basis of formulation, the global mouth ulcers treatment market has been categorized into gel, spray, mouthwash, and lozenge. In 2013, gels held the largest share of the market, owing to the low cost of the products, easy availability at leading medical stores, and increasing preference from medical practitioners. However, the lozenges segment is anticipated to grow at a rapid pace in the forecast period. The global mouth ulcers treatment market is segmented according to indication into oral lichen planus, aphthous stomatitis, and others. Among these, in 2013, the aphthous stomatitis indication segment dominated the global mouth ulcers treatment market and is estimated to grow bearing the highest growth rate in the forecast period. The dominance of this segment was due to its growing prevalence. Furthermore, the global mouth ulcers treatment market has been segmented on the basis of drug class into antimicrobial, anesthetic, corticosteroid, analgesic, and antihistamine. In most cases, mouth ulcers do not need a particular treatment; however, if the ulcers get severe, medication is needed to reduce inflammation and pain.
Browse the full Press Release Report : http://www.transparencymarketresearch.com/pressrelease/mouth-ulcers-treatment-market.htm
The research report segments the global mouth ulcers treatments market for the purpose of geographical analysis into North America, Europe, Asia Pacific, and Rest of the World. In 2013, North America dominated the global mouth ulcers treatment market in terms of revenue and was further followed by Europe.The research report has provided a detailed analysis of the players operating in the global mouth ulcers treatment market. The analysis comprises key facts, company overview, product segmentation, business strategies, and recent development in the industry. Some of the players mentioned in the research report are Pfizer, Inc., 3M, Church & Dwight Co., Inc., Bristol-Myers Squibb Company, Taro Pharmaceutical Industries Ltd.,GlaxoSmithKline plc, BLISTEX, INC., The Colgate-Palmolive Company, and ECR Pharmaceuticals.
Request a Brochure of this Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=2747
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Alternative Sweetener Market - Global Industry Analysis, Size, Share, Growth and Foreca... - 2 views
-
The global alternative sweetener market is expected to witness steady growth during the forecast period. Increasing demand for healthier low-calorie food products is one of the major factors boosting the demand for alternative sweeteners globally. Manufacturers aim to launch other sugar substitutes due to rising health consciousness among consumers. In addition, rising prices of sugar helps to boost the growth of the alternative sweetener market gradually.
Browse Full Alternative Sweetener Market Report With Complete TOC @
http://www.transparencymarketresearch.com/alternative-sweetener-market.html
A recent study reveals that low-calorie sweeteners do not increase the risk of cancer. Natural alternative sweeteners are useful in managing calorie count, cutting down on carbohydrates, and improving overall health. Growing obesity rate, increasing diabetic population, and other health problems are fueling the demand for low-calorie sugar-free products.
Furthermore, overconsumption of diet sodas and colas that contain sucralose, aspartame, or saccharin may cause health problems such as diabetes, obesity, and heart diseases. People consuming diet sodas may suffer from the risk of metabolic syndrome and cardiovascular disease. Artificial sweeteners are increasingly preferred over table sugar among health-conscious consumers, as they virtually contain no calories.
In terms of product type, the market is segmented into high fructose syrup (HFS), high intensity sweetener (HIS), and low intensity sweetener (LIS). In terms of applications, alternative sweeteners are broadly divided into beverages such as diet-carbonated soft drinks, ready-to-drink tea and coffee, juices; and food products such as confectionaries, tabletop sweeteners, chewing gum, chocolate, bakery products, and dairy products. In addition, alternative sweeteners are used in personal care products such as toothpaste, mouthwash, and glycerin as well as in pharmaceutical products. High intensity sweetener is the most popular form of sweetener among consumers, followed by high fructose syrup. Low intensity sweeteners and polyols are gradually replacing high intensity sweeteners and high fructose syrup in the global food and beverage segment.
The report also includes drivers, restraints and opportunities (DROs) of the alternative sweetener market. The study highlights current market trends and provides the forecast from 2015 to 2021. We have also covered the current market scenario for alternative sweeteners and highlighted its future trends that are likely to affect the demand for alternative sweeteners.
Browse Full Press Release Report :
http://www.transparencymarketresearch.com/pressrelease/alternative-sweetener-market.htm
By geography, the market has been segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). The present market size and forecast until 2021 are covered in the report. North America held the largest market share of the alternative sweetener market in 2014. Market growth of this region is due to increasing problem of obesity and other health issues such as cardiovascular diseases and diabetes. Therefore, food and beverage manufacturers are focusing on producing low calorie, sugar free products to meet the consumers need in North America. Apart from this, rising obesity rate causes the declining of soft drinks consumption in North America and Europe and that implies the fall in usage of high intensity sweetener in these regions. Owing to this, the demand for artificial sweetener is decreasing in these regions and a significant shift in preferences and behavior from carbonated soft drinks was seen in Europe and North America. Asia Pacific held the second largest share in 2014 followed by Europe and RoW of the global alternative sweetener market.
The report also analyzes different factors influencing and inhibiting the growth of the alternative sweetener market. The market attractiveness analysis provided in the report highlights key investing areas in this industry. The report will help alternative sweetener manufacturers, suppliers, and distributors understand the present and future trends in this market and formulate their business strategies accordingly.
Key players in the alternative sweetener market include Tate & Lyle Plc, Cargill, Incorporated, Ajinomoto Co., Inc., Archer-Daniels-Midland Company, Ingredion Incorporated, Roquette Frères S.A., and The NutraSweet Company.
The scope of the study presents a comprehensive evaluation of the stakeholder strategies and winning imperatives for them by segmenting the alternative sweetener market as below:
Global alternative sweetener market has been segmented as follows:
Global alternative sweetener market, by product type
High Fructose Syrup (HFS)
High Intensity Sweetener (HIS)
Low Intensity Sweetener (LIS)
Global alternative sweetener market, by application
Food
Beverages
Others (including pharmaceuticals and personal care etc)
In addition, the report provides cross-sectional analysis of all the above segments with respect to the following geographies:
Global alternative sweetener, by geography
North America
U.S.
Canada
Rest of North America
Europe
Germany
U.K.
France
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
Rest of Europe
Rest of the World (RoW)
Latin America
Middle East
Other countries in RoW
Request a Brochure of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=4792
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
North America Milk Market to Exhibit 3.5% CAGR from 2013 to 2019 due to Rising Health C... - 2 views
-
A new market research report has been recently published by Transparency Market Research, a U.S.-based market research and intelligence firm. The research report provides an in-depth analysis of the milk market in North America, including market overview, product segmentation, and competitive analysis. The research report is titled "North America Milk Market - Scenario, Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019".
Browse the full North America Milk Market - Scenario, Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019 report at http://www.transparencymarketresearch.com/north-america-milk-market.html
According to the report, in 2012, the North America milk market stood at US$27.81 billion and in 2013, it was valued at US$29.1 billion. Going further, the milk market is projected to touch US$35.8 billion by the end of 2019, growing significantly at a 3.5% CAGR between 2013 and 2019. In terms of volume of milk consumption, in 2013, the North America milk market was pegged at 17.96 billion kg and is estimated to grow to 21.05 billion kg by the end of 2019, growing positively at a 2.13% CAGR through the forecast period.
Rising health concerns among consumers, increasing demand for new and innovative products such as flavored milk, and widening distribution channels such as hypermarkets and supermarkets are some of the major factors expected to fuel the growth of the North America milk market in the forecast period. On the other hand, availability of a wide range of substitutes such as almond milk, soy milk, and others, and short shelf life of milk and dairy products are the restraining factors anticipated to curb the growth of this market in the coming years.On the basis of products, the North America milk market has been segmented into powder milk, liquid milk, butter milk, and concentrated milk. Among all the product categories, concentrated milk is growing rapidly in the North America milk market. This segment is estimated to grow progressively at a 3.47% CAGR in the forecast period. On the other side, the liquid milk segment is also anticipated to grow significantly in the coming years, owing to the rising awareness among consumers regarding the health and daily nutritional requirement of the human body.
Browse the full Press Release Report: http://www.transparencymarketresearch.com/pressrelease/north-america-milk-market.htm
For the purpose of geographical study, the North America milk market has been segmented into three regions, namely Mexico, the U.S., and Canada. Among these regions, the U.S. is the biggest producer of milk and other dairy products. The rising demand from the U.S. can be attributed to increasing health issues and need for food that contains high levels of nutrients.
Furthermore, the research report discusses the competitive landscape of the North America milk market. In 2013, in the U.S., the Dairy Farmers of America accounted for the largest market share. Some of the prominent players operating in Canada are Neilson, Dairy land, and Parmalat, which held the largest share of the market in 2013. In the same year, GrupoLala led the market in Mexico. Some of the other leading players in the North America milk market are Saputo Inc., Dean Foods Co., and Groupe Danone.
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=2562
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
U.S., Europe and Japan Orthopedic Soft Tissue Surgical Procedures Market Expected to Re... - 1 views
-
U.S., Europe and Japan Orthopedic Soft Tissue Surgical Procedures Market (Rotator Cuff Repair, Vaginal Prolapse, Lateral Epicondylitis, Achilles Tendinosis Repair, Gluteal Tendon/Trochanteric Bursitis Repair and Anterior Cruciate Ligament (ACL) Reconstruction): Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
According to a new market report published by Transparency Market Research "U.S., Europe and Japan Orthopedic Soft Tissue Surgical Procedures Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" the U.S., Europe and Japan orthopedic soft tissue surgical procedures market was valued at USD 7.3 billion in 2013 and is estimated to reach a market worth of USD 10.2 billion in 2020 growing at a CAGR of 4.9% from 2014 to 2020.
Browse the full U.S., Europe and Japan Orthopedic Soft Tissue Surgical Procedures Market report at http://www.transparencymarketresearch.com/soft-tissue-repair-sports-medicine.html
The report on U.S., Europe and Japan orthopedic soft tissue surgical procedures market studies market size of rotator cuff repair, vaginal prolapse, lateral epicondylitis, achilles tendinosis repair, gluteal tendon repair and anterior cruciate ligament reconstruction (ACL). Rising number of sport related injuries coupled with growth of active aging population in the developed regions would boost the demand of orthopedic soft tissue surgeries. According to the American Academy of Orthopaedic Surgeons (AAOS) and the American Orthopaedic Society for Sports Medicine, over 150,000 anterior cruciate ligament (ACL) injuries occur each year in the U.S. alone. Additionally, introduction of high cost and innovative surgical repair products and increasing incidence of obesity have raised the demand of orthopedic surgeries thereby propelling market growth. For example, Biomet, Inc. launched JuggerKnotless Soft Anchor device in July 2014 which featured company's all-suture anchor technology. This device enables the repair of rotator cuff damage with better restoration and high efficacy. Growing acceptance of minimally invasive soft tissue surgical techniques (arthroscopy procedures) has enabled the completion of soft tissue surgeries in shorter time with lesser complication rates. This factor is also increasing the uptake of soft tissue surgeries. However, asymptomatic nature of soft tissue surgeries and high threat from conservative therapy are anticipated to restrain the market growth.
In terms of various surgical procedures ACL reconstruction accounted for the largest share of the market in 2013. ACL reconstruction is also likely to retain its dominant position in the future as it is the most common knee injury that requires surgical intervention. Rising participation in sports such as football, basketball and others along with increasing number of patients opting for reconstructive surgeries due to introduction of minimally invasive surgeries would fuel the growth of this segment. Similarly, launch of bio-absorbable which nullifies the risk related to implant removal would also aid in increasing the market size for ACL reconstruction. The market of gluteal tendon repair accounted for the smallest share in 2013 owing to large pool of patients being treated by non-operative methods such as pain killers and steroid injection for this condition.
Browse the full Press Release Report:
http://www.transparencymarketresearch.com/pressrelease/us-soft-tissue-repair-sports-medicine.htm
soft-tissue-repair-sports-medicine-market
Geographically, the U.S. orthopedic soft tissue surgical procedures market captured major market revenue in 2013 and is expected to dominate the market during the forecast period from 2014 to 2020. Rising population base, increasing urge to stay healthy among geriatric population and improving healthcare coverage would contribute towards the growth of orthopedic soft tissue surgical procedures in this region. The orthopedic soft tissue surgical procedures market in Europe is anticipated to grow at a CAGR of 4.7% due to increasing number of sports related injuries. According to "Injuries in the European Union" published by EuroSafe, sports related injuries accounted for around 14% of the total injuries in the European Union. Similarly, a survey conducted by the professionals in Europe in 2010 concluded that the annual prevalence of people consulting for shoulder pain was 2.4% in the U.K.; most of these were attributed to rotator cuff injuries. Thus, increasing incidences of soft tissue injuries would propel the market growth in this region.
The orthopedic soft tissue surgical procedures market is fragmented in nature and is dominated by players, namely Arthrex, Inc., Smith & Nephew, plc., DePuy Synthes, Inc., Stryker Corporation., CONMED Corporation, and ArthroCare Corporation. Of all these, Arthrex was identified as the largest player in this market in 2013 followed by Smith & Nephew and Depuy Synthes, Inc.
The U.S., Europe and Japan orthopedic soft tissue surgical procedures market is segmented as follows:
U.S. Orthopedic Soft Tissue Surgical Procedures Market, by Indications
Rotator Cuff Repair
Vaginal Prolapse
Lateral Epicondylitis
Achilles Tendinosis Repair
Gluteal Tendon Repair
Anterior Cruciate Ligament (ACL) Reconstruction
Europe Orthopedic Soft Tissue Surgical Procedures Market, by Indications
Rotator Cuff Repair
Vaginal Prolapse
Lateral Epicondylitis
Achilles Tendinosis Repair
Gluteal Tendon Repair
Anterior Cruciate Ligament (ACL) Reconstruction
Japan Orthopedic Soft Tissue Surgical Procedures Market, by Indications
Rotator Cuff Repair
Vaginal Prolapse
Lateral Epicondylitis
Achilles Tendinosis Repair
Gluteal Tendon Repair
Anterior Cruciate Ligament (ACL) Reconstruction
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1768
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Albumin (Excipient) Market Expected to Reach USD 0.8 Billion Globally in 2020 - 1 views
-
According to a new market report published by Transparency Market Research "Albumin (Excipient) Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast, 2014 - 2020," the global albumin excipient market was valued at USD 704.9 million in 2013 and is expected to grow at a CAGR of 2.3% from 2014 to 2020, to reach an estimated value of USD 828.2 million by 2020.
Browse the full Albumin (Excipient) Market Report at http://www.transparencymarketresearch.com/albumin-market.html
Selection of appropriate excipients is very important during the development of drug formulations and vaccines. A suitable excipient helps stabilize and protect an active pharmaceutical ingredient (API) in the formulation against degradation, oxidation or aggregation that the API could undergo during manufacturing, transport and storage. As an excipient, albumin has wide applications in drug formulation, drug delivery, vaccine manufacturing and as a component of media for the production of vaccines. Manufacturers are increasingly considering innovative ways to reduce contamination risks of finished products due to the recent incidents of animal virus contamination of biopharmaceutical products. Manufacturers must adhere to strict regulations on the standards and also provide detailed information on the country of origin (BSE free), the types of tissue used and details of the manufacturing process during the compliance and approval procedure.
The global albumin market is analyzed by albumin type, applications and geography. On the basis of type, the market is segmented into human serum albumin, bovine serum albumin and recombinant albumin. Human serum albumin was the largest segment and was valued at USD 476.7 million in 2013. The segment is expected to reach USD 557.0 million in 2020, growing at a CAGR of 2.2% during the forecast period between 2014 and 2020. Bovine serum albumin is used in the production of vaccines such as MMR II, Varivax, Zostavax and RotaTeq in ranges of less than 1 ppm. Extensive research to explore new ways is underway to increase virus yield and quality in manufacturing. Recently, end-user preference has been observed to have shifted towards recombinant human albumin (rAlbumin) used in multiple applications such as in nano formulation and drug carrier over specific therapeutic modalities. Advances in yeast-based protein expression and the successful scale-up have led to the development of an industrial-scale manufacturing process that can produce a highly pure, animal-free rAlbumin suitable for use as an excipient in biotherapeutics.
albumin-market
Primary applications of albumin include drug formulation and drug delivery, vaccines, and component of media. The drug formulation and drug delivery segment is expected to reach USD 395.9 million in 2020. Expansion of the role of albumin in drug delivery has widened the field of nanotechnology as well. For instance, Abraxis BioScience has applied nanotechnology to human serum albumin (HSA) with its nanoparticle albumin-bound, known as 'NAB' technology platform. This approach combines HSA with an API for delivering protein drugs.
Geographically, North America continues to dominate the market due to high demand for albumin in drug formulations, and research and development activities. The albumin market in the region was valued at USD 253.8 million in 2013. The current focus of the research community in most of the academic institutions and industry is to use albumin as a carrier for micro- and nanoparticles for sustained-release injectable drugs. Paclitaxel nano-particulate formulation containing albumin as a carrier was approved by the U.S. FDA in September 2013. Countries such as China, India and Australia exhibit significant growth prospects in terms of rapid increase in the research collaboration between industry and research institutions. GlaxoSmithKline Pharmaceuticals Limited (GSK) is funding around USD 4 million per year to initiate research and development program with the leading research institutions in Asia Pacific for the development of potential therapeutics.
Browse the full Press Release Report: http://www.transparencymarketresearch.com/pressrelease/albumin-market.htm
Some of the major companies operating in the global albumin market are CSL Behring, HiMedia, InVitria, Mitsubishi Tanabe Pharma, Octapharma AG, Novozymes A/S, Raybiotech, Inc., Sigma-Aldrich Corporation, Thermo Fischer Scientific, Inc. and MedxBio Pte. Ltd. Pharmaceutical companies and research institutes obtain the desired albumin excipient grade from the market players for their development activities. The key players in the global albumin market improve their distribution network by entering into strategic alliances and distributorship agreements. For instance, InVitria partnered with Thermo Fischer Scientific and Sigma-Aldrich in order to provide its customers with product support best tailored to meet their needs. InVitria has distributors across the world including North America, Europe, Asia and Australia.
The global albumin market is segmented as follows:
Albumin Market Revenue (USD Million), by Type
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin
Albumin Market Revenue (USD Million) and Volume (kg), by Application
Drug Formulation and Drug Delivery
Vaccines
Component of Medium
Albumin Market Revenue (USD Million) and Volume (kg), by Geography
North America
Europe
Asia Pacific
Rest of the World
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=3984
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Rising Preference for Generic Drug Variants to Negatively Impact Global Kidney Cancer D... - 1 views
-
According to the latest research report released by Transparency Market Research, the global kidney cancer drugs market is expected to grow consistently at a CAGR of 6.6% during the period between 2014 and 2020. The report titled "Kidney Cancer Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" forecasts that in 2013, the global kidney cancer drugs market was worth US$2.6 billion and with consistent growth, the market will be valued at US$4.5 billion by 2020.
Browse the full Kidney Cancer Drugs Market report at
http://www.transparencymarketresearch.com/kidney-cancer-drugs-market.html
According to the World Cancer Research Fund International, kidney cancer is the twelfth most common cancer in the world. Also known as Renal Cell Carcinoma (RCC), it is associated with smoking, obesity, and reduced physical activity. The report mentions that the rise in the reported cases of kidney cancer worldwide along with rising geriatric population will fuel the growth of the global kidney cancer drugs market. The report cites that the growth of the global kidney cancer drugs market will get fuelled by the approval and commercialization of novel molecules in treating kidney cancer. However, the high cost of the drugs will deter the growth of the global kidney cancer drugs market. The report predicts that the increasing preference of generic drug variants will negatively impact the global kidney cancer drugs market.
The report studies the global kidney cancer drugs market depending upon the major branded drug used by the patients. Votrient, Inlyta, Avastin, Torisel, Proleukin, Afinitor, Sutent, and Nexavar are the major branded drug segments of the global kidney cancer drugs market. In 2013, Sutent dominated the global kidney cancer drugs market with more than 30% of the market share. Sunitinib (marketed as Sutent by the drug-manufacturing giant Pfizer) has been often used as the first-line treatment for renal cell carcinoma. The report suggests that the high price of the drug is expected to slow down the growth of this drug segment and the segment will reflect a sluggish growth at 1.1% from 2012 to 2016 and at 2.1% CAGR from 2016 to 2020. Votrient is predicted to be the fastest growing segment of the global kidney cancer drugs market. It is projected to take a leap at 41.7% CAGR during the period between 2012 and 2016. The growth of this segment will slow down considerably from 2016 to 2020 to a CAGR of 8.9%.
The report segments the global kidney cancer drugs market on the basis of the potential pipeline drugs to be launched during the forecast horizon. Cabozantinib, AGS-003, Dovitinib, Opdivo, and Keytruda are some of the drugs expected to be launched and commercialized during the period between 2012 and 2016, thereby strengthening the overall global kidney cancer drugs market.
Browse the full Press Release Report:
http://www.transparencymarketresearch.com/pressrelease/kidney-cancer-drugs-market.htm
Geographically, the report segments the global kidney cancer drugs market into four key regions: North America, Asia Pacific, Europe, and Rest of the World. North America was the largest region of the global kidney cancer drugs market, accounting for more than 45% share. Due to the U.S. being the largest pharmaceutical market worldwide, the overall cancer drugs market receives the highest revenue for each of the drug segments from the country. The U.S. accounts for more than 90% of the global kidney cancer drugs market in North America, followed by Canada, which fills up the remaining market share in the region. The report mentions that the kidney cancer drugs market in Asia Pacific region will grow at a CAGR of 6% due to the rising demand from countries such as Australia, Japan, New Zealand, and China.
The global kidney cancer drugs market is highly consolidated with GlaxoSmithKline, Novartis AG, and Pfizer Inc. being some of the key players. Pfizer dominated more than 40% of the global kidney cancer drugs market in 2013.
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=537
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Transparency Market Research Projects U.S. Vaccine Market to be Valued at USD 17.4 bill... - 1 views
-
Data from a new report published by Transparency Market Research "U.S. Vaccine Market - U.S. Industry Analysis, Size, Share, Growth, And Forecast, 2012 - 2018", estimates the U.S. vaccine market to be worth USD 12.8 billion in 2012 and further expected to reach USD 17.4 billion by 2018, growing at a CAGR of 5.3% from 2012 to 2018.
Browse Full U.S. Vaccine Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/us-vaccine-market.html
Vaccines for different disorders and illnesses are included among the leading earners in the pharmaceutical industry. Over the recent years, enhanced research and development in this market has led to the production of better-quality and effective drugs and vaccines to treat various illnesses. The vaccine sales in U.S. are growing rapidly at a faster rate as compared to the other prescription medicines in the market. U.S. has showed a substantial revenue growth in the vaccine production market increasing the enormity of this industry as well.
The vaccine sales are chiefly resistive to the generic competition that is quoting drug makers billions of dollars in revenues on each of their top-selling vaccine treatments. Moreover, government supporting agencies are unfailing buyers of the vaccine products both in the U.S., as well as across the globe. Hence, U.S. is focused on continuing to lead the global vaccine market amongst other markets in the world. This drive is also due to the rising prevalence of infectious diseases in animals and humans, and improvements seen in the biotechnology sector across U.S.
According to the industry best market research firms' surveys, many U.S. pediatricians claimed that over half of the U.S. population have parental concerns about general vaccines and child immunization. It is for such reasons, pediatric vaccine segment in the U.S. human vaccine market takes pride in holding the highest market share, as well as high growth rate because of government compulsion for child immunization. The adult & adolescent vaccine market in the
U.S. is expected to grow judiciously over the next six years due to increasing awareness for human papillomavirus (HPV) and other viral diseases.
On the other hand, the livestock vaccine is another leading segment across the U.S. Due to an increased awareness towards protecting infectious diseases in cattle, rising vaccination to prevent breeding animals against illnesses and disorders, and organizing the entire dairy sector, this market accounted for 58.1% of the total shares in 2012. The Bovine vaccine sector in the United States is considered to be the largest revenue generating sector in the present day.
Browse Full Press Release Report:
http://www.transparencymarketresearch.com/pressrelease/us-vaccine-market.htm
However, in 2011, the feline vaccine and canine vaccine also accounted for approximately 95.1% shares in the overall U.S. companion animal vaccine market.
This report includes more information about the generalized overview of the U.S. vaccine market including definitions, applications, and global market industry structure. It discusses the ephemeral shelf-life of certain vaccines available in the market and how they will have a negative impact on the overall market size and growth. However, the report also includes the market analysis of the overall vaccine industry that has multinational firms working on huge product pipeline in order to overcome all the shortcomings and restraints. The report provides extensive analysis of the U.S. vaccine market and the factors that will further revolutionize this industry towards a massive growth.
Among all the geographical regions, U.S. Vaccine Market is considered to be the largest in the history of vaccine. Since 2011, there have been some significant leading producers of human vaccine for the U.S. market and the names included are Merck, Sanofi-Aventis, Pfizer, GlaxoSmithKline, Sanofi-Pasture and Novartis. Similarly, for the animal vaccine market, the leading producers of animal vaccine for the U.S. market includes Merial (Sanofi-Aventis), Pfizer Animal Health, Novartis Animal Health, and Intervet/Schering-Plough (Merck).
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=553
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Diabetic Food Market is expected to reach USD 11,098.0 million by 2020 - 0 views
-
Transparency Market Research has published a new market report titled Diabetic Food Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2020. According to the report, the global diabetic food market was valued at USD 7,418.6 million in 2013 and is anticipated to reach USD 11,098.0 million by 2020, expanding at a CAGR of 5.9% from 2014 to 2020. North America dominated the global diabetic food market in 2013 and is expected to maintain its leading position over the forecast period. Consumer awareness about health benefits associated with low calorie diabetic food products is propelling the growth of the diabetic food market globally.
Browse Full Diabetic Food Market Report With Complete TOC @
http://www.transparencymarketresearch.com/diabetic-food-market.html
diabetic-food-market
Rising consumer concern about healthy eating habits coupled with changing food preference is stimulating the demand for diabetic food products globally. Moreover, growing number of diabetic patients and other health complications associated with diabetes are playing a crucial role in boosting the demand for diabetic food. The U.S., U.K., Germany, China and India are some of the major markets for diabetic food. Furthermore, increasing concern to maintain a healthy lifestyle is boosting the demand for diabetic foods in Rest of the World (RoW).
People with high blood sugar levels are prone to stroke and heart attack. Furthermore, eye complications and nerve problems are among the major side effects of high blood sugar. Manufacturers are keen on introducing new low calorie food products with sugar substitutes and less oil, in view of the increasing consumer interest toward healthy eating. Furthermore, food manufacturers are also concentrating on strengthening and widening their distribution channels in order to ensure better accessibility of diabetic food products to consumers globally.
Unilever Plc, Nestle S.A., PepsiCo Inc., The Coca-Cola Company, Cadbury plc, Kellogg Company, Mars, Inc., Fifty 50 Foods, Inc., and David Chapman's Ice Cream Limited have strong global presence with their wide range of diabetic food products.
Browse Full Press Release Report:
http://www.transparencymarketresearch.com/pressrelease/diabetic-food-market.htm
The global diabetic food market has been segmented as follows:
Global Diabetic Food Market by Application Type
Dietary beverages
Ice cream and jellies
Dairy products
Confectionery
Baked products
Others
Global Diabetic Food Market by Region and Country
North America
U.S.
Rest of North America
Europe
UK
Germany
France
Scandinavia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
Rest of Asia Pacific
Rest of the World
Latin America
Middle East
Africa
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=b&rep_id=1828
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact
Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Beer Market - Latin America and Middle-East Industry Analysis, Size, Share, Growth, Tre... - 1 views
-
Beer is a type of alcoholic beverage produced by fermentation and saccharification of starch of the resulting sugar. The enzymes and starch are generally derived from malted grains, cereals. Beers are also added with hops that include bitterness and also act as a natural preservative. Other flavorings such as herbs and fruit are occasionally included. The process of preparing beer is known as brewing.
Browse Full Latin America and Middle-East Beer Market Report With Complete TOC @
http://www.transparencymarketresearch.com/latin-america-middle-east-beer-market.html
After water, beer is consumed most widely and is the third most popular drink after tea and water. The presence of alcohol in a beer accounts to 4% to 6%. The basic ingredients of beer are starch source such as malted barley, water, a brewer's yeast to produce the fermentation and also a flavoring like hops.
Increasing health concerns among consumers, increasing availability of beer are some of the factors driving the Latin America and Middle-East beer market. Increasing obesity, high cholesterol is some of the major concern hindering the growth of the market. It is seen that consumption of beer proved to be beneficial for people to prevent such coronary diseases. Beer is low in cholesterol, low in fat that helps in preventing high cholesterol disease. Moreover, consumption of beer moderately regulates the cholesterol ratios. Due to favorable climatic condition in the region of Latin America and Middle-East consumption of beer is increasing along with the increasing availability of beer. Increasing disposable income along with rapid urbanization is also driving the beer market in this region. Rapid urbanization offer better opportunity for the rise in demand of beer in the beer market.
However, stringent government rules and regulation and sensorial profile of beer are the restraining factors of beer market in the region of Middle-East. Latin America has the largest market share of beer and is expected to have a moderate growth during the forecast period. In Middle-East there are strict rules and regulation due to which consumption of beer is less compared to Latin America. Consumption of Alcoholic beer in Saudi Arabia is strictly prohibited. Due to this reason consumption of non-alcoholic beer is more in Saudi Arabia compared to any other region. Increasing disposable income along with rapid urbanization has a high impact on the demand of beer in the long run. The manufactures of beer are now manufacturing organic beer which has organic ingredients. This is fuelling the demand of beer during the forecast period.
Browse Full Press Release Report :http://www.transparencymarketresearch.com/pressrelease/latin-america-middle-east-beer-market.htm
Carlsberg Group, Ambev S.A, Anheuser-Busch InBev, Heineken N.V and SABMiller Plc are some of the major players of beer in the region of Latin America and Middle-East beer market.
The report has been segmented by geography and product type and it includes drivers, opportunities and restraints, Porters Five Forces analysis of the Latin America and Middle-East beer market. The research study highlights present provides forecasts and market trends from 2015 to 2021. Average selling prices (ASP) across all product segments and packaging sizes are also covered within the scope of research. We have featured the current market scenario for the beer market and identified future trends that will impact demand for beer during the forecast period.
By product type, the market is segmented into dark, lager, non-alcoholic and stout beer. The report provides the present market size and anticipates its status over the forecast period. By geography the market has been segmented into two i.e. Latin America and Middle-East.
The report also analyzes factors driving and inhibiting expansion in the beer market. Porter's Five Forces analysis offers insights into the market competition across its value chain. The report will assist suppliers, manufacturers, and distributors to understand the present and future trends in the market and formulate strategies accordingly.
The report segments the sports nutrition market as:
Beer Market, by Product
Dark beer
Lager beer
Non-alcoholic beer
Stout beer
Non-Alcoholic Drinks Market, by Geography:
Latin America
Middle-East
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=b&rep_id=4539
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Automotive Engine Management System Market - Global Industry Analysis, Size, Share, Gro... - 2 views
-
This is a market research report which undergoes an in-depth analysis of automotive engine management system market from a global perspective and provides estimates in terms of revenue (USD billion) from 2015 to 2021. Comprehensive analysis of the automotive engine management system market from all the different dimensions of the market is provided in the report. It includes the drivers and restrains impacting the market. The report also analyses the impact of the drivers, restrains and opportunities over the forecast period. Market opportunities of automotive engine management system are also included in the report. Automotive engine management system is forms an integral part of passenger cars, LCV and HCV. Engine management system is one of the main components as it receives valuable information from fuel pumps, ECU, engine sensors and controls the engine accordingly.
Browse Full Automotive Engine Management System Market Report With Complete TOC @
http://www.transparencymarketresearch.com/automotive-engine-management-systems-market.html
The reasons for substantial growth in demand for automotives are increase in GDP and per-capita income in the countries of Asia Pacific. This is one of the main factors responsible for increase for the demand in the automotive engine management system market. Moreover, the increasing awareness about environment is also supported the growth of fuel efficient engine management system. ECU, engine sensor and fuel pump are some of the main components of the automotive engine management system.
One of the most attractive regions in automotive engine management system market is Asia-Pacific. Increase in purchasing power due to easy availability of credit facilities and technological upgradation along with the rise of upper middle class in the Asia Pacific region are the major factors increasing the demand for automotive engine management system market. Infrastructural development in the Asia-Pacific is also driving the automotive engine management system market as it increases the demand for LCV's and HCVs'. Moreover, emerging countries such as India and China manufacture a large number of automotives in the Asia Pacific region which also drives the demand for automotive engine management system. Asia Pacific is followed by Rest of the world (ROW) from the market attractiveness point of view. Presence of countries like Saudi Arabia, UAE, Brazil and South Africa has lead to the significant growth in the automotive engine management system market due to increase in demand of automotives. However, Europe held the maximum market share for automotive engine management system. The reason for this in the presence of eminent automotive manufacturers like BMW, Mercedes Benz, Volkswagen and strict pollution control norms prevailing in Europe.
The report is sub-divided by engine type, vehicle type and geography. The report includes the market drivers, restraints, and opportunities of the automotive engine management system market. Current market trends are also highlighted in the study and provide the forecast from 2015 to 2021. Future trends that will influence demand in the coming years are also included in the report. The report has been segmented into North America, Europe, Asia-Pacific and Rest of the World based on region. The current market size, market trends and market scenario from 2015 and are also include in the report.
Strategic analysis of the global automotive engine management system market and the growth forecast for the period 2015 to 2021 is also provided in the report. The span of the report includes competitive analysis of various market segments based on the types, module and in-depth cross sectional analysis of the automotive engine management system market across different geographic segments. The types of automotive engine management system market include gasoline engine and diesel engine. Company profiles of leading market players are also included in this report to provide a backup of the market in a more detailed way. Market attractiveness analysis included in the report provides in-depth analysis into market dynamics and industry competition.
Browse Full Press Release Report :
http://www.transparencymarketresearch.com/pressrelease/automotive-engine-management-systems-market.htm
Company market share analysis of the various industry participants along with company overview, financial and business strategies and recent developments in the field of automotive engine management system market are also provided in the report. Major market participants profiled in this report include Continental AG, Denso Corporation, Robert Bosch, Sensata Technologies, Delphi Automotive Plc, Hella Kgaa Hueck & Co, Hitachi Ltd, Infineon Technologies AG, Sensata Technologies, Sanken Electric Company Ltd and BorgWarner Inc among others.
The Global Automotive Engine Management System Market has been segmented as follows:
Global Automotive Engine Management System Market: By Geography
North America
Europe
Asia Pacific
Rest of the World
The report provides a cross-sectional analysis of all the below segments with respect to the above mentioned regions.
Global Automotive Engine Management System Market: By Engine Type
Gasoline
Diesel
Global Automotive Engine Management System Market: By Vehicle Type
Passenger car
LCV
HCV
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=b&rep_id=4176
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
« First
‹ Previous
61 - 80 of 105
Next ›
Last »
Showing 20▼ items per page
Rising incidence of hospital acquired infectious diseases and increase in the number of surgeries in hospitals is expected to drive the sterilizers and surgical, dental care, and equipment disinfectors market in India. Factors that drive the growth of the sterilization equipment and disinfectants market in India are large pool of geriatric population, rise in prevalence of cancer and increasing number of hospital-acquired infections (HAIs). Furthermore, increase in per capita healthcare expenditure would also propel the growth of this market. According to Trading Economics, disposable personal income in India increased to approximately INR 80,663,730 million in 2012 from INR 71,787,870 million in 2011. Additionally, the market is likely to witness steady growth in technological advancements such as introduction of radiation-based sterilization techniques (gamma and E-beam sterilization) during the forecast period due to high product compatibility and low cost. Negligence towards sterilization measures in hospitals might restrain market growth. Moreover, increasing acceptance of single use and disposable medical device is another major restraint to the chemical sterilizers market.
sterilizers-surgical-dental-care-equipment-disinfectors-market
Government measures to provide adequate healthcare services in remote parts of nation have substantially increased the number of hospitals in the last few years. Furthermore, growing medical tourism in India is also driving the market growth. To further elucidate, heart bypass surgery in India costs USD 5,200 (approx. INR 3.3 Lakhs) while it costs USD 144,000 (Approx. INR 91 Lakhs) in the U.S. Low treatment cost in India is attracting patients across the world and is expected to drive growth of the sterilizers and surgical, dental care, and equipment disinfectors market during the forecast period. According to an article published by the Times of India in September 2014, India is among the top three medical tourism destinations in Asia, primarily due to low cost of treatment, availability of highly skilled specialists, and sophisticated health care infrastructure. However, growing inclination towards single use and disposable instruments due to its consistency and safety has affected the India sterilizers and surgical, dental care and equipment disinfectors market in last few years.
Chlorhexidine gluconate, alcohol, povidone-iodine, benzalkonium chloride, octenidine hydrochloride, ethyl-hexadecyl-dimethyl ammonium and others (aldehydes, hydrogen peroxide, hypochlorites and chlorine based disinfectors) collectively form the chemical formulations market; among which chlorhexidine gluconate based formulations accounted for the largest market share and is expected to lead the position during the forecast period due to the high safety, better efficacy and high usage adoption rate among hospitals and patients. Similarly, within the general hospitals application segment usage of chemical sterilizers and disinfectors were observed to be highest in wound care. Increasing number surgical procedures and rising number of trauma cases are few of the major factors that are boosting the application of sterilizers and disinfectors in wound care segment. Furthermore, within end-users segment operating rooms, ICUs and nursing tables segment accounted for the largest market share and is anticipated to lead the market during the forecast period due to high usage of chemical disinfectors used for disinfecting the equipment used during surgeries. Similarly, within the surgery stages segment post-operative surgery stage account for the largest market share due to the due to increasing risk of infection caused by a number of microbes, their growing drug resistance, and extended hospital stay after the surgery.
Key players profiled in this research report include 3M, Advanced Sterilization Products Services, Inc., Antrix Hygiene Ltd., Ipca Laboratories Ltd., Medi-Vet Animal Health, LLC, PSK Pharma Private Limited, Raman & Weil Pvt. Ltd., Ranbaxy Laboratories Ltd., Reckitt Benckiser Group plc, Sanosil Biotech Pvt. Ltd., Schülke India Pvt. Ltd., UPS Hygienes Pvt. Ltd., Win-Medicare Pvt. Ltd., and Zep Superior Solutions. The end-users (hospitals) profiled in this study are Apollo Hospitals Enterprise Ltd., Fortis Healthcare Limited, and Wockhardt Hospitals.
Browse the full Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market (By Chemical Formulations, By Applications, By End-users & By Surgery Stages) India Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 report at http://www.transparencymarketresearch.com/sterilizers-surgical-dental-care-equipment-disinfectors-market.html
The India sterilizers and surgical, dental care and equipment disinfectors market is segmented into the following categories:
Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market, by Chemical Formulations
Chlorhexidine Gluconate Based Formulations
Alcohol Based Agents
Povidone-Iodine Based Formulations
Benzalkonium Chloride Based Formulations
Octenidine Hydrochloride Based Formulations
Ethyl - hexadecyl - dimethyl Ammonium Based Formulations
Others (Aldehydes, Hydrogen Peroxide, Hypochlorites and Chlorine Based Disinfectors)
Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market, by Applications
Hospitals
General Hospitals
Wound Care
Burn Care
Ulcer Care
Dental Care Centers
Surgical Care
Diagnostic Care
Veterinary Care Centers
Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market, by End-users
Patients and Caregivers
Hospital and Nursing Staff
Operating Rooms, ICUs and Nursing Tables
Equipment and Devices used during Surgery
Others (Veterinary and Diagnostic Care Centers)
Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market, by Surgery Stages
Pre-operative
Intra-operative
Post-operative
Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=4681
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Mr. Nachiket Ghumare
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/